United States · FDA National Drug Code directory
Drax Exametazime
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65174-200_9799f139-0c16-4cf0-8a7d-e9668ec3f146
- Product NDC
- 65174-200
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Kit for the Preparation of Technetium Tc 99m Exametazime for Leukocyte Labeling
- Labeler
- Jubilant DraxImage Inc., dba Jubilant Radiopharma
- Marketing category
- NDA
- Marketing start / end (source format)
- 20170817
- Source listing expiry
- 20261231
Source-listed ingredients
- TECHNETIUM TC-99M EXAMETAZIME — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 5 VIAL in 1 CARTON (65174-200-05) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (65174-200-01) · 65174-200-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →